Michael Almstetter;Roland Koestler;Andreas Treml;Michael Thormann;Nasser Yehia
发明人:
Michael Thormann,Andreas Treml,Michael Almstetter,Roland Koestler,Nasser Yehia
申请号：
US13506509
公开号：
US09499535B2
申请日:
2012.04.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to novel compounds of formula (I)that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases.
